AMRX

Amneal Pharmaceuticals, Inc. Healthcare - Drug Manufacturers - Specialty & Generic Investor Relations →

NO
144.3% ABOVE
↑ Moving away Was 132.2% last week
-15% -10% -5% 0% 5% 10% 15%+
Buy Threshold $5.94
14-Week RSI 87

Amneal Pharmaceuticals, Inc. (AMRX) closed at $14.52 as of 2026-02-02, trading 144.3% above its 200-week moving average of $5.94. The stock moved further from the line this week, up from 132.2% last week. With a 14-week RSI of 87, AMRX is in overbought territory.

Over the past 356 weeks of data, AMRX has crossed below its 200-week moving average 3 times. On average, these episodes lasted 77 weeks. Historically, investors who bought AMRX at the start of these episodes saw an average one-year return of +55.1%.

With a market cap of $4.6 billion, AMRX is a mid-cap stock. The company generates a free cash flow yield of 4.8%. The stock trades at -41.7x book value.

Share count has increased 107.4% over three years, indicating dilution.

Over the past 6.9 years, a hypothetical investment of $100 in AMRX would have grown to $106, compared to $260 for the S&P 500. AMRX has returned 0.9% annualized vs 14.8% for the index, underperforming the broader market over this period.

Free cash flow has been volatile over the past several years, making the quality of earnings harder to assess.

Growth of $100: AMRX vs S&P 500

Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.

What Happens After AMRX Crosses Below the Line?

Across 3 historical episodes, buying AMRX when it crossed below its 200-week moving average produced an average return of +42.3% after 12 months (median +98.0%), compared to +22.0% for the S&P 500 over the same periods. 67% of those episodes were profitable after one year. After 24 months, the average return was +73.0% vs +53.7% for the index.

Each line shows $100 invested at the moment AMRX crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.

Advertisement

Historical Touches

AMRX has crossed below its 200-week MA 3 times with an average 1-year return of +55.1% after recovery.

Crossed BelowRecoveredWeeksMax Depth1-Year ReturnReturn Since Touch
Apr 2019Jul 202322483.4%-73.3%+14.3%
Aug 2023Sep 202344.7%+115.5%+289.3%
Oct 2023Oct 2023311.7%+123.2%+278.1%
Average77+55.1%

Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.

Data as of Friday close, 2026-02-02